Health
AHA: New Medication, Finerenone, Helps Heart Health in People With Chronic Kidney Disease, Type 2 Diabetes – Cath Lab Digest
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events…
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2020. The virtual meeting is Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based…
-
Noosa News17 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General19 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business24 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General23 hours agoStocks, dollar sink as trade war roils markets